Suppr超能文献

南非性工作者和男男性行为者场所客户口服暴露前预防药物的使用、持续使用和停药的影响因素。

Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa.

机构信息

Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

FHI 360, Durham, North Carolina, United States of America.

出版信息

PLoS One. 2020 Apr 30;15(4):e0228620. doi: 10.1371/journal.pone.0228620. eCollection 2020.

Abstract

BACKGROUND

South Africa became the first country in Africa to introduce oral PrEP in June 2016. The National Department of Health has used a phased approach to rollout, allowing for a dynamic learn-and-adapt process which will lead ultimately to scale-up. Phased rollout began with provision of oral PrEP at facilities providing services to sex workers in 2016 and was expanded in 2017, first to facilities providing services to MSM and then to students at selected university campus clinics, followed by provision at primary health care facilities. Programmatic data shows variability in initiation and continuation between these populations. This study examines factors related to PrEP initiation, continuation, and discontinuation at facilities providing services to sex workers and MSM during the national PrEP rollout.

METHODS

A cross-sectional survey was administered September 2017-January 2018 among clients (ages 18-62 and providers at 9 facilities implementing oral PrEP in South Africa, followed by in-depth interviews. The client survey captured PrEP initiation, continuation and discontinuation. Analysis was performed in STATA 13 for survey data and thematic analysis was performed in NViVO 11 for in-depth interview data.

RESULTS

299 clients (203 from sex worker facilities, 96 from MSM facilities) participated in the survey and additionally, in-depth interviews were conducted with 29 clients. Participants self-identified as either current users (n = 94; 36.2%), past users (n = 80; 30.8%) and never users of PrEP (n = 86; 33.1%). Participants who had never used PrEP either cited not being offered PrEP by a provider (57%, n = 49) or declining PrEP (43%, n = 37) as reasons for lack of uptake. The primary reason for declining to use oral PrEP was fear of side effects (41.7%, n = 15). The primary reasons for initiating and continuing on oral PrEP were all related to perceived risk associated with sexual activity. The majority of participants (87.9%, n = 153) also noted that printed IEC materials influenced their decision to initiate PrEP. Qualitative data suggested that several clients initiated on PrEP because they wanted additional protection beyond using condoms due to challenges such as partners refusing to use condoms, having partners with unknown HIV status, having multiple partners, involvement in sex work, or having a partner living with HIV. The majority (73.8%, n = 59) of participants who discontinued oral PrEP cited side effects as the primary reason for discontinuation, followed by feeling stigmatized (18.8%, n = 15).

CONCLUSION

This study provides valuable insights on early rollout of PrEP of how clients perceive oral PrEP and where to target efforts to improve the uptake of this highly effective HIV prevention product. By identifying strengths and areas for improvement, the ACCESS study has generated evidence that can be used to guide high quality scale-up in South Africa and may be instructive for other countries' efforts to expand quality access to oral PrEP.

摘要

背景

南非于 2016 年 6 月成为非洲第一个引入口服 PrEP 的国家。南非国家卫生部采用分阶段的方法推出该项目,为最终扩大规模提供了一个动态的学习和适应过程。分阶段推出始于为提供性工作者服务的设施提供口服 PrEP,并于 2017 年扩大,首先是为男男性行为者提供服务的设施,然后是为选定大学校园诊所的学生提供,随后在初级保健设施提供。项目数据显示,这些人群之间在开始和继续使用 PrEP 方面存在差异。本研究调查了在全国 PrEP 推出期间,为性工作者和男男性行为者提供服务的设施中 PrEP 开始、继续和停止使用的相关因素。

方法

2017 年 9 月至 2018 年 1 月期间,在南非实施口服 PrEP 的 9 个设施中,对客户(年龄在 18-62 岁之间)和提供者进行了横断面调查,随后进行了深入访谈。客户调查记录了 PrEP 的开始、继续和停止使用情况。在 STATA 13 中对调查数据进行了分析,在 NViVO 11 中对深入访谈数据进行了主题分析。

结果

299 名客户(203 名来自性工作者设施,96 名来自男男性行为者设施)参加了调查,此外,还对 29 名客户进行了深入访谈。参与者自我认定为当前使用者(n = 94;36.2%)、过去使用者(n = 80;30.8%)和从未使用者(n = 86;33.1%)。从未使用过 PrEP 的参与者要么表示提供者未提供 PrEP(57%,n = 49),要么表示拒绝 PrEP(43%,n = 37),这是他们未接受 PrEP 的原因。拒绝使用口服 PrEP 的主要原因是担心副作用(41.7%,n = 15)。开始和继续使用口服 PrEP 的主要原因都与性活动相关的风险感知有关。大多数参与者(87.9%,n = 153)还表示,印刷的信息、教育和宣传材料影响了他们开始使用 PrEP 的决定。定性数据表明,由于一些参与者的伴侣拒绝使用避孕套、伴侣 HIV 状况未知、有多个伴侣、参与性工作或伴侣患有 HIV 等挑战,一些参与者开始使用 PrEP 是因为他们希望在使用避孕套之外获得额外的保护。大多数(73.8%,n = 59)停止使用口服 PrEP 的参与者表示副作用是停止使用的主要原因,其次是感到被污名化(18.8%,n = 15)。

结论

本研究提供了有关 PrEP 早期推出的宝贵见解,了解了客户对口服 PrEP 的看法,以及在哪里可以努力提高这种高效 HIV 预防产品的使用率。通过识别优势和改进领域,ACCESS 研究提供了可以用于指导南非高质量扩大规模的证据,也可能为其他国家扩大高质量口服 PrEP 服务提供参考。

相似文献

引用本文的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验